# FDA recall D-916-2013

> **Medicis Pharmaceutical Corp** · Class II · drug recall initiated 2013-05-01.

## Product

CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CA 90806, Kit is comprised of: Daily Care Foaming Cleanser (Salicylic Acid 2%) NDC 62032-111; Pore Therapy (Salicylic Acid 2%) NDC 62032-110 and Therapeutic Lotion (Benzoyl Peroxide 5%) NDC 562032-113). Product under recall is the Pore Therapy (Salicylic Acid 2%), NDC 62032-110.

## Reason for recall

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

## Distribution

Nationwide, Great Britain, Mexico, Russia and The Ukraine.

## Key facts

- **Recall number:** D-916-2013
- **Recalling firm:** Medicis Pharmaceutical Corp
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-01
- **Report date:** 2013-08-28
- **Termination date:** 2014-04-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Scottsdale, AZ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-916-2013

## Citation

> AI Analytics. FDA recall D-916-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-916-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*